ProNAi Therapeutics (DNAI) Priced

Developing cancer therapies based on DNA interference.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.56 0.00 (0.0%)
First Day Return 81.2%
Return from IPO -90.8%
 
ProNAi Therapeutics IPO News more
  • .
IPO Data
IPO File Date 06/12/2015
Offer Price $17.00
Price Range $17.00 - $17.00
Offer Shares (mm) 8.1
Deal Size ($mm) 138
 
IPO Data
IPO Date 07/15/2015
Offer Price $17.00
Price Range $17.00 - $17.00
Offer Shares (mm) 8.1
Deal Size ($mm) $138
 
Underwriters
more
Business Overview
Developing cancer therapies based on DNA interference.
Developing cancer therapies based on DNA interference.
more
Company Data
Headquarters Vancouver, , Canada
Founded 2003
Employees 40
Website www.pronai.com
 

Performance vs. IPO Index (IPOUSA)